Literature DB >> 14715846

Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.

L De Marinis1, A Bianchi, A Mancini, R Gentilella, M Perrelli, A Giampietro, T Porcelli, L Tilaro, A Fusco, D Valle, R M Tacchino.   

Abstract

Obesity is characterized by increased leptin levels and insulin resistance, whereas blunted GH secretion is paired with normal, low, or high plasma IGF-I levels. To investigate body composition in human obesity and the interactions among the GH-IGF-I axis, leptin, and insulin resistance [measured with the homeostasis model assessment (HOMA) score], we studied 15 obese females, aged 23-54 yr (mean age, 42.7 +/- 2.6), with a body mass index (BMI) of 44.02 +/- 1.45 kg/m(2), who underwent treatment by biliopancreatic diversion (BPD), before and after surgery (16-24 months; BMI, 28.29 +/- 0.89 kg/m(2)). Our controls were 15 normal females, aged 28-54 yr (mean age, 40.8 +/- 2.3 yr), with a BMI of 27.52 +/- 0.53 kg/m(2). Insulin and leptin levels and HOMA scores were higher pre-BPD than in the controls. The GH response to GHRH was blunted, with a GH peak and GH area under the curve (AUC) significantly lower than those in controls. IGF-I and IGF-binding protein-3 (IGFBP-3) were also lower than control values. After surgery, BMI, fat mass, lean body mass, HOMA, insulin, and leptin significantly decreased. Furthermore, the GH response to GHRH severely increased; IGF-I and IGFBP-3 levels did not significantly vary. Considering all subjects, correlation analysis showed a strong positive correlation between insulin and leptin, and a negative correlation between insulin and GH peak and between insulin and GH AUC. Regression analysis performed grouping pre- and post-BPD indicated that leptin and GH peak or AUC could best be predicted from insulin levels. The surgical treatment of severe obesity after stabilization of body weight decreases BMI and fat mass while preserving normal lean body mass as well as positively influencing insulin sensitivity and thus aiding the normalization of leptin levels. The insulin reduction may be mainly involved in the increase in the GH response to GHRH through various possible central and peripheral mechanisms while decreasing the peripheral sensitivity to GH itself, as shown by the stable nature of the IGF-I and IGFBP-3 values. Our findings suggest that the changes in insulin levels are the starting point for changes in both leptin levels and the somatotrope axis after BPD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715846     DOI: 10.1210/jc.2002-021308

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Changes in plasma levels of ghrelin, leptin, and other hormonal and metabolic parameters following standardized breakfast, lunch, and physical exercise before and after a multidisciplinary weight-reduction intervention in obese adolescents.

Authors:  A E Rigamonti; F Agosti; A De Col; N Marazzi; C L Lafortuna; S G Cella; E E Muller; A Sartorio
Journal:  J Endocrinol Invest       Date:  2010-03-25       Impact factor: 4.256

2.  Decrease in insulin resistance has a key role in improvement of metabolic profile during intragastric balloon treatment.

Authors:  Gorana Mirošević; Marko Nikolić; Ivan Kruljac; Neven Ljubičić; Miroslav Bekavac-Bešlin; Milan Milošević; Borka Pezo Nikolić; Vladimir Supanc; Ivan Budimir; Milan Vrkljan
Journal:  Endocrine       Date:  2013-10-17       Impact factor: 3.633

3.  Growth hormone-releasing hormone is produced by adipocytes and regulates lipolysis through growth hormone receptor.

Authors:  F Rodríguez-Pacheco; C Gutierrez-Repiso; S García-Serrano; A Ho-Plagaro; J M Gómez-Zumaquero; S Valdes; M Gonzalo; J Rivas-Becerra; C Montiel-Casado; G Rojo-Martínez; E García-Escobar; E García-Fuentes
Journal:  Int J Obes (Lond)       Date:  2017-06-19       Impact factor: 5.095

Review 4.  The immune remodel: Weight loss-mediated inflammatory changes to obesity.

Authors:  Charles L Phillips; Bernadette E Grayson
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-19

Review 5.  Endocrine changes (beyond diabetes) after bariatric surgery in adult life.

Authors:  S Savastano; C Di Somma; R Pivonello; G Tarantino; F Orio; V Nedi; A Colao
Journal:  J Endocrinol Invest       Date:  2013-02-27       Impact factor: 4.256

6.  Insulin and IGF-I inhibit GH synthesis and release in vitro and in vivo by separate mechanisms.

Authors:  Manuel D Gahete; José Córdoba-Chacón; Qing Lin; Jens C Brüning; C Ronald Kahn; Justo P Castaño; Helen Christian; Raúl M Luque; Rhonda D Kineman
Journal:  Endocrinology       Date:  2013-05-13       Impact factor: 4.736

7.  GH/GHRH axis in HIV lipodystrophy.

Authors:  Takara L Stanley; Steven K Grinspoon
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

8.  Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets.

Authors:  Kathrin Maedler; Pavel Sergeev; Jan A Ehses; Zoltan Mathe; Domenico Bosco; Thierry Berney; Jean-Michel Dayer; Manfred Reinecke; Philippe A Halban; Marc Y Donath
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

9.  Growth Hormone Dynamics in Healthy Adults Are Related to Age and Sex and Strongly Dependent on Body Mass Index.

Authors:  Ferdinand Roelfsema; Johannes D Veldhuis
Journal:  Neuroendocrinology       Date:  2015-07-28       Impact factor: 4.914

10.  Long- but not short-term adult-onset, isolated GH deficiency in male mice leads to deterioration of β-cell function, which cannot be accounted for by changes in β-cell mass.

Authors:  Jose Cordoba-Chacon; Manuel D Gahete; Naveen K Pokala; David Geldermann; Maria Alba; Roberto Salvatori; Raul M Luque; Rhonda D Kineman
Journal:  Endocrinology       Date:  2013-12-16       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.